Page 3 of 3
123

2013 (3 POSTS)

Thompson CM, Gaylor DW, Tachovsky JA, Perry C, Carakostas MC, Haws LC. 2013. Development of a chronic noncancer oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. J Appl Toxicol 33(12):1395-1406; doi: 10.1002/jat.2799.

View Abstract

2012 (3 POSTS)

Kopec AK, Kim S, Forgacs AL, Zacharewski TR, Proctor DM, Harris MA, Haws LCThompson CM. 2012. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol 259(1):13-26; doi: 10.1016/j.taap.2011.11.012.

View Abstract

Thompson CMProctor DMSuh MHaws LC, Hebert CD, Mann JF, Shertzer HG, Hixon JG,Harris MA. 2012. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: Implications for carcinogenic modes of action. Toxicol Sci 125(1):79-90; doi: 10.1093/toxsci/kfr280.

View Abstract

O’Brien TJ, Hao D, Suh M, Proctor D, Thompson CM, Harris MA, Parsons BL, Meyers MB. 2012. K-ras codon 12 GGT to GAT mutation is not elevated in the duodenum of mice subchronically exposed to hexavalent chromium in drinking water. Presented at the Society of Toxicology’s 51st Annual Meeting, March 11-15, San Francisco, CA.

View Abstract

2011 (3 POSTS)

Thompson CPerry C, Gaylor D, Tachovsky A, Burkhalter B, Haws L. Derivation of an oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. Presented at Society of Toxicology 50th Annual Meeting, Washington DC, March 2011.

View Abstract

Haws L, Proctor D, Thompson C, Harris M. Research plan to fill data gaps in the mode of action for cancer risk assessment of hexavalent chromium in drinking water. Presented at  Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

View Abstract

Proctor D, Meek B. Using mode of action data to guide quantitative cancer risk assessment: A case study of hexavalent chromium in drinking water. Presented at Society of Toxicology 50th Annual Meeting, Washington, DC, March 2011.

View Abstract

2010 (1 POST)

Racz L, Goel RK. 2010. Fate and removal of estrogens from municipal wastewater. J Environ Monit 12(1):58–70; doi: 10.1039/b917298j.

View Abstract

2008 (1 POST)

Staskal DF, Donovan EP, Haws LC, Roberts JD, Unice KM, Finley BL, Harris MA. Human health risks associated with exposure to pathogens in waters and sediments of the Lower Passaic River. Presented at Society of Toxicology 47th Annual Meeting, Seattle, WA, 2008.

2007 (1 POST)

Staskal, DF, Donovan EP, Haws LC, Roberts JD, Unice KM, Finley BL, Harris MA. A quantitative microbial risk assessment for exposure to pathogens in waters and sediments of the Lower Passaic River. Society for Risk Analysis Annual Meeting, San Antonio, TX, 2007.

2006 (1 POST)

Buffler PA, Kelsh MA, Lau EC, Edinboro CH, Barnard JC, Rutherford GW, et al. 2006. Thyroid function and perchlorate in drinking water: An evaluation among California newborns, 1998. Environ Health Persp 114(5):798–804; doi: 10.1289/ehp.8176. PMID: 16675440.

View Abstract
Page 3 of 3
123